Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
Top Cited Papers
- 31 December 2009
- Vol. 59 (1), 105-110
- https://doi.org/10.1136/gut.2009.180570
Abstract
Objectives: Recent studies suggest that cardiac dysfunction precedes development of the hepatorenal syndrome. In this follow-up study, we aimed to investigate the relation between cardiac and renal function in patients with cirrhosis and ascites and the impact of cardiac systolic function on survival. Patients and design: Twenty-four patients with cirrhosis and ascites were included. Cardiac function was investigated by gated myocardial perfusion imaging (MPI) for assessment of cardiac index (CI) and cardiac volumes. The renal function was assessed by determination of glomerular filtration rate (GFR) and renal blood flow (RBF) and the patients were followed up for 12 months. Results: In patients with a CI below 1.5 l/min/m(2) on MPI, GFR was lower (39 (SD 24) vs 63 (SD 23) ml/min, p = 0.03), RBF was lower (352 (SD 232) vs 561 (SD 229) ml/min, p = 0.06), and serum creatinine was higher (130 (SD 46) vs 78 (SD 29) mmol/l, p<0.01). The number of patients who developed hepatorenal syndrome type 1 within 3 months was higher in the group with low CI than in the high CI group (43% vs 5%, p = 0.04). Patients with the lowest CI (N = 8) had significantly poorer survival at 3, 9, and 12 months compared to those with a higher CI (N = 16), p<0.05. In contrast, the Model for End-stage Liver Disease (MELD) score failed to predict mortality in these patients. Conclusions: The development of renal failure and poor outcome in patients with advanced cirrhosis and ascites seem to be related to a cardiac systolic dysfunction. Other parameters may be more important than MELD score to predict prognosis.This publication has 15 references indexed in Scilit:
- The management of portal hypertension: Rational basis, available treatments and future optionsJournal of Hepatology, 2008
- Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndromeHepatology, 2007
- Cirrhotic cardiomyopathyDigestive and Liver Disease, 2007
- Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndromeJournal of Hepatology, 2007
- The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the sceneEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Gated SPECT in assessment of regional and global left ventricular function: Major tool of modern nuclear imagingJournal of Nuclear Cardiology, 2006
- Circulatory function and hepatorenal syndrome in cirrhosisHepatology, 2005
- EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitisHepatology, 2003
- Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of diseaseJournal of Hepatology, 2003